CATHERINE MARCUCCI: Open Payments
NPI 1174801278 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,867 in 78 payments from 31 companies in 2025. Trend: 2023 $166 · 2024 $1,545 · 2025 $3,867
Food & beverage: $2,334Consulting: $1,395Education: $138
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 7 | $1,399 |
| Syndax Pharmaceuticals, Inc. | 2 | $255 |
| ABBVIE INC. | 5 | $224 |
| Novartis Pharmaceuticals Corporation | 7 | $195 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $191 |
| Cardinal Health 110 LLC | 2 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $168 |
| Astellas Pharma US Inc | 1 | $126 |
| Legend Biotech USA Inc. | 2 | $105 |
| SEAGEN INC. | 1 | $93 |
Products named: EPKINLY, REVUFORJ, SCEMBLIX, CALQUENCE, Vyloy, CARVYKTI, PYRUKYND, Vonjo.
Industry payments across TN — which companies pay providers there.
